Showing results (221-230 of 337) with videos related to
Sort By:
Pageof 34
Nature Genetics|March 1, 1995
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3P L Tavormina, R Shiang, L M Thompson, et al.American Journal of Medical Genetics|July 16, 1999
Small deletions in the type II collagen triple helix produce kniest dysplasiaD J Wilkin, A S Artz, S South, et al.Nature Genetics|July 1, 1995
Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein geneM D Briggs, S M Hoffman, L M King, et al.Current Oncology (Toronto, Ont.)|January 10, 2013
Cost-effectiveness of zoledronic acid compared with clodronate in multiple myelomaT E Delea, K El Ouagari, J Rotter, et al.Drug Metabolism Reviews|June 28, 2022
Novel insights in drug transporter sciences: the year 2021 in reviewParesh P Chothe, Pallabi Mitra, Masanori Nakakariya, et al.The American Journal of Medicine|December 1, 1988
Hermansky-Pudlak syndrome: an immunologic assessment of 15 casesF Shanahan, L Randolph, R King, et al.Drug Metabolism Reviews|August 30, 2023
Drug transporters in drug disposition - the year 2022 in reviewParesh P Chothe, Pallabi Mitra, Masanori Nakakariya, et al.Drug Metabolism Reviews|June 23, 2026
Drug Transporters in Drug Disposition - Highlights from the Year 2025Philip Sandoval, Pallabi Mitra, Masanori Nakakariya, et al.The Journal of Clinical Investigation|March 13, 1999
Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosisW S Hou, D Brömme, Y Zhao, et al.Lancet (London, England)|October 24, 1981
Close genetic linkage between diabetes mellitus and kidd blood groupS E Hodge, C E Anderson, K Neiswanger, et al.Pageof 34